Physician

Jonathan Allen Miller, M.D.

According to 2025 Medicare claims, Jonathan Miller, M.D. (NPI: 1346637048) practices micrographic dermatologic surgery in the Chattanooga, TN-GA market, with the plurality of this provider's patient population coming from Hamilton, TN. This provider's primary affiliated billing organization is UDERM, PLLC (NPI: 1255938502; TIN: 844131688) and primary practice location at 37343-4862.

Miller's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,072 traditional Medicare patients, billed 5,418 HCPCS/CPT codes, and received $717,586 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 1,620 prescription claims across 908 beneficiaries totaling $140,028 in drug costs, led by Clobetasol Propionate (Clobetasol Propionate). Open Payments data shows 51 records totaling $969. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $20,870 to $717,586. Similarly, Part D prescription costs have moved sharply higher in recent years, from $2,649 to $140,028. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$359K$718K2017 Medicare payment: $20,870 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $10,135 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $8,362 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $117,756 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $286,172 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $474,666 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $578,426 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $717,586 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017185632$20,870
201891291$10,135
201967289$8,362
2020173903$117,756
20214373,287$286,172
20227625,469$474,666
20238934,777$578,426
20241,0725,418$717,586

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$70K$140K2015 Drug cost: $2,649 (USD; Tot_Drug_Cst)2016 Drug cost: $8,723 (USD; Tot_Drug_Cst)2017 Drug cost: $16,786 (USD; Tot_Drug_Cst)2018 Drug cost: $24,025 (USD; Tot_Drug_Cst)2019 Drug cost: $20,521 (USD; Tot_Drug_Cst)2020 Drug cost: $23,788 (USD; Tot_Drug_Cst)2021 Drug cost: $40,028 (USD; Tot_Drug_Cst)2022 Drug cost: $112,617 (USD; Tot_Drug_Cst)2023 Drug cost: $84,432 (USD; Tot_Drug_Cst)2024 Drug cost: $140,028 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R17$2,649
201630103$8,723
2017100213$16,786
2018138321$24,025
2019119314$20,521
2020142263$23,788
2021301698$40,028
20225121,111$112,617
20237321,315$84,432
20249081,620$140,028

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks393531$385
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more459583$56
11102Biopsy of related skin growth, first growth246291$54
17000Destruction of precancer skin growth, 1 growth347442$32
17003Destruction of precancer skin growth, 2-14 growths2641,352$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Clobetasol PropionateClobetasol Propionate912,583$6,400
FluorouracilFluorouracil661,808$5,239
MupirocinMupirocin6189,480$4,457
Doxycycline HyclateDoxycycline Hyclate4063,235$3,021
KetoconazoleKetoconazole732,181$1,272

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.51$969SUN PHARMACEUTICAL INDUSTRIES INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jonathan Allen Miller, M.D.?

Tedicare shows public-source Medicare data for Jonathan Allen Miller, M.D. (NPI 1346637048), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jonathan Allen Miller, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jonathan Allen Miller, M.D.?

Jonathan Allen Miller, M.D. is linked to UDERM, PLLC (billing NPI 1255938502) in the available physician profile data.

Does Jonathan Allen Miller, M.D. have Open Payments data?

Jonathan Allen Miller, M.D. has 51 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.